China’s biopharmaceutical market is currently at a pivotal juncture. In the face of multidimensional challenges and industry trends—such as the capital winter, geopolitical shifts, the surge in innovative drugs, emerging new modalities, the push for globalization, and the rise of NewCos—how should industry stakeholders navigate these opportunities, challenges, and breakthrough paths?

To promote the continuous upward development of the biopharmaceutical industry, BioCon China Expo 2025 (12th International Biopharmaceutical Conference and Exhibition) will take place in Hangzhou, China, on July 3–4, 2025, organized by BioMap Global. With the theme "Uniting for Innovation and Win-Win Synergy", the conference will feature three dedicated frameworks. The international summit forum will evaluate key development trends and foster global exchanges in the biomedical field. The investment and financing cooperation forum will focus on matching and financing innovative drug projects. The innovative drug technology forum will cover the entire lifecycle of biopharmaceutical development—from drug discovery and CMC processes to quality analysis and international commercialization. Moreover, it will highlight trending fields such as antibody drugs, ADCs, XDCs, cell and gene therapies, nucleic acids, polypeptides, and radiopharmaceuticals. This conference will lead the way in advancing new technologies, promoting collaboration across the entire industrial chain, and driving ecosystem convergence for mutual success in the biomedical field.

Over the years, BioCon has become one of the most prestigious and enduring annual conferences in China's biopharmaceutical field, witnessing the growth and success of the industry's early pioneers, returning overseas entrepreneurs, and leading Chinese biopharmaceutical companies. Founded in 2014, BioCon has stood by those in the bio and pharma field through over 11 years of trials and tribulations. Initially established in China Wuhan, the conference has since flourished and expanded its presence in Shanghai, then extended its reach to Singapore, and ultimately found its permanent home in Hangzhou. Up to now, BioCon has attracted more than 30,000  professionals from the global biopharmaceutical community. Furthermore, over 1,100 prominent industry leaders and experts have shared their insights and engaged in profound discussions throughout the event.

BioCon China Expo 2024 was successfully held in Beijing on April 10-11, 2024. In collaboration with a diverse group of specialists, the conference showcased a comprehensive and high-quality experience featuring "conference + exhibition + match + activities" over the course of two days. The event was attended by over 170 key representatives from government regulatory agencies, clinical sectors, R&D, and the biopharmaceutical industry.